Claim library

Has FDA flagged "weight loss"?

Yes. FDA has quoted wording matching "weight loss" in at least 30 warning letters in our database. The most recent is FDA's June 8, 2026 letter to Trinity HealthCare Supply, LLC dba altRx.

Checked against published FDA warning letters, updated November 15, 2026.

Letters that quote it

Each quote is copied from the company's marketing as FDA printed it in the letter.

…clinically proven weight loss.

Trinity HealthCare Supply, LLC dba altRx, June 8, 2026
Read the FDA letter

For: Type 2 Diabetes Treatment Weight Loss Cardiovascular Protection

FormPour, March 31, 2026
Read the FDA letter

GLP-1 SM (Semaglutide) Uses: Weight Loss Dosing: Start: 0.25mg weekly. Titrate up to: 2.5mg weekly.

Mile High Compounds LLC, March 31, 2026
Read the FDA letter

Clinically proven to aid in significant weight loss in overweight adults.

Peaks Curative, LLC dba Peaks, February 20, 2026
Read the FDA letter

Hit weight management goals with the same weight loss ingredient as brand-name GLP-1 medications, at a fraction of the cost

Kin Meds, February 20, 2026
Read the FDA letter

Clinically Proven Weight Loss

Mane & Steel, LLC. dba Mane & Steel, September 9, 2025
Read the FDA letter

The same active ingredient in branded weight loss medications.

Canada Med Stop, September 9, 2025
Read the FDA letter

Clinically Proven Weight Loss – Semaglutide has been shown to….

Lyfe Rx, September 9, 2025
Read the FDA letter

At home weight loss with the popular Ozempic generic Semaglutide.

Expert Aesthetics, September 9, 2025
Read the FDA letter

Semaglutide for weight loss - Prefilled Syringes, similar to Ozempic or Wegovy

ybycmeds, September 9, 2025
Read the FDA letter

Compounded Generic Semaglutide is a revolutionary FDA-inspected medication for rapid weight loss that is given once weekly.

The HCG Institute, September 9, 2025
Read the FDA letter

Semaglutide is the generic drug in Ozempic (injectable) and Rybelsus (oral) diabetes control medications, and Wegovy (injectable) weight loss medication.

ASN-LABS, September 9, 2025
Read the FDA letter

Semaglutide is the generic drug delivered in Ozempic (injectable) and Rybelsus (oral) diabetes control medications, and Wegovy (injectable) weight loss medication.

GLP-1 Solution, September 9, 2025
Read the FDA letter

Tirzepatide is a compound that has been shown to help with weight loss…

USApeptide.com, February 26, 2025
Read the FDA letter

Top Peptides for Weight Loss: A Quick Guide

Prime Vitality, Inc. dba Prime Peptides, December 10, 2024
Read the FDA letter

Showing the 20 most recent. See every match in the free check.

Why FDA quotes wording like this

Warning letters quote a company's own marketing as evidence of how a product is being sold. Under the Federal Food, Drug, and Cosmetic Act, a product promoted to cure, treat, mitigate or prevent disease is a drug, so disease claims on a supplement, CBD or wellness product can make it an unapproved drug. Some letters quote wording like "FDA approved" or "clinically proven" for other reasons. Each letter states its own charges, so read the source before deciding anything.

This page is informational and is not legal advice.

Is "weight loss" anywhere on your website?

FDA letters quote blog posts, FAQ answers and social captions, not just product pages. Our $39.99 report checks every page of your site against every letter in our database, with a link to each match.